Korro Bio (KRRO) Other Non Operating Income (2018 - 2026)
Korro Bio (KRRO) posted Other Non Operating Income of $906000.0 for Q1 2026, down 8.48% on a QoQ basis from $990000.0 in Q4 2025, and down 44.52% year-over-year from $1.6 million in Q1 2025.
Korro Bio (KRRO) Other Non Operating Income (2018 - 2026) Analysis & Trends
Korro Bio's Other Non Operating Income history runs 9 years deep, the most recent figure standing at $906000.0 for Q1 2026.
- Quarterly Other Non Operating Income fell 44.52% year-over-year to $906000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.5 million (down 44.99% YoY) and the FY2025 annual result came in at $5.2 million, down 38.23% from the prior year.
- Other Non Operating Income was $906000.0 for Q1 2026 at Korro Bio, down from $990000.0 in the prior quarter.
- Across five years, Other Non Operating Income topped out at $2.3 million in Q2 2024 and bottomed at -$227000.0 in Q2 2022.
- A 5-year average of $1.1 million and a median of $990000.0 in 2025 frame the typical range for Other Non Operating Income.
- Annual changes were most pronounced in 2022 — Other Non Operating Income sank 22600.0% — and 2023, when it surged 1557.58%.
- Korro Bio's Other Non Operating Income stood at $619000.0 in 2022, then surged by 137.0% to $1.5 million in 2023, then jumped by 32.52% to $1.9 million in 2024, then slumped by 49.07% to $990000.0 in 2025, then dropped by 8.48% to $906000.0 in 2026.
- Business Quant data shows KRRO's Other Non Operating Income at $906000.0 in Q1 2026, $990000.0 in Q4 2025, and $1.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Korro Bio | 123.70 Mn | 9.73 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 906,000.00 |
| Dec 31, 2025 | 990,000.00 |
| Sep 30, 2025 | 1.18 Mn |
| Jun 30, 2025 | 1.43 Mn |
| Mar 31, 2025 | 1.63 Mn |
| Dec 31, 2024 | 1.94 Mn |
| Sep 30, 2024 | 2.28 Mn |
| Jun 30, 2024 | 2.33 Mn |
| Mar 31, 2024 | 1.91 Mn |
| Dec 31, 2023 | 1.47 Mn |
| Sep 30, 2023 | 656,000.00 |
| Jun 30, 2023 | 786,000.00 |
| Mar 31, 2023 | 481,000.00 |
| Dec 31, 2022 | 619,000.00 |
| Sep 30, 2022 | 617,000.00 |
| Jun 30, 2022 | -227,000.00 |
| Mar 31, 2022 | -33,000.00 |
| Sep 30, 2021 | -139,000.00 |
| Jun 30, 2021 | -1,000.00 |
| Mar 31, 2021 | 21,000.00 |